Medical Device News Magazine

The AGA Research Foundation Provides over $2 million in Funding to Promising Researchers

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The American Gastroenterological Association (AGA) is excited to announce the 17 researchers selected to receive funding through the AGA Research Foundation Awards Program. The 2020 award year will provide $2.2 million in research funding to support outstanding investigators working on projects that will enhance our understanding of gastrointestinal and liver conditions and ultimately lead to better treatment options for patients with digestive disorders.

“This year’s selected awardees are committed to transforming the gastroenterology field with their research projects that span the entire digestive tract,” said Robert S. Sandler, MD, MPH, AGAF, chair, AGA Research Foundation. “We are excited to continue the foundation’s tradition of excellence with the support of many gifted early career researchers and look forward to seeing how their research evolves with this funding.”

Of the 2020 class of awardees, half are female and 12% are from racial or ethnic groups traditionally underrepresented in biomedical research. In line with the AGA Research Foundation’s mission to support the next generation of researchers in digestive diseases, 71% of the 2020 awardees are early-career investigators. Approximately one-third are performing clinical research.

RESEARCH SCHOLAR AWARDS

AGA Research Scholar Award 

  • Andrea Geisz, PhD, Boston University Henry M. Goldman School of Dental Medicine, Massachusetts
  • Haifa Mtaweh, MD, The Hospital for Sick Children, Toronto, Canada
  • Long H. Nguyen, MD, MS, Massachusetts General Hospital and Harvard Medical School, Boston
  • Shuang Wang, PhD, Icahn School of Medicine at Mount Sinai, New York City

AGA-Gastric Cancer Foundation Ben Feinstein Memorial Research Scholar Award in Gastric Cancer 

  • Samuel J. Klempner, MD, Massachusetts General Hospital, Boston

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease 

  • José Ordovas-Montañes, PhD, Boston Children’s Hospital, Massachusetts

SPECIALTY AWARDS

AGA-Caroline Craig Augustyn & Damian Augustyn Award in Digestive Cancer 

  • Peter S. Liang, MD, MPH, New York University Langone Health, New York City

AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer 

  • Ajay Goel, PhD, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Monrovia, California

 

PILOT AWARDS

AGA-Allergan Foundation Pilot Research Award in Inflammatory Bowel Disease 

  • Chun-Jun Guo, PhD, Weill Cornell Medicine, New York City

AGA-Allergan Foundation Pilot Research Award in Nonalcoholic Fatty Liver Disease 

  • Jun Wu, PhD, University of Michigan, Ann Arbor

AGA-Elsevier Pilot Research Award 

  • Hien Dang, PhD, Thomas Jefferson University, Philadelphia, Pennsylvania
  • Tirthadipa Pradhan-Sundd, PhD, University of Pittsburgh, Pennsylvania

AGA-Pfizer Young Investigator Pilot Research Award in Inflammatory Bowel Disease 

  • Mallory Chavannes, MD, MHSc, Children’s Hospital Los Angeles, California
  • Trevor M. Darby, PhD, MS, Emory University, Atlanta, Georgia
  • Michael Howitt, PhD, Stanford University School of Medicine, California

AGA-Rome Foundation Functional Gastrointestinal and Motility Disorders Pilot Research Award 

  • Nitin Kumar Ahuja, MD, MS, University of Pennsylvania, Philadelphia
  • Bindu Chandrasekharan, PhD, Emory University, Atlanta, Georgia

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”